Secondary Metabolites by Chemical Screening, 41
at 28 °C in a 2-litre fermentor, using 900 mL of medium A. The (125.7 MHz, CDCl3): δ ϭ 19.4 (14-Me), 23.6 (C-12), 30.9 (C-11),
FULL PAPER
fermentor was inoculated with 10 vol-% of a pre-culture grown for
72 h in a rotary shaker at 250 rpm and 28 °C. The precursor was
added to the culture as a sterile aqueous solution, adjusted to pH
6.5, during the 24th and 30th h, and the culture was harvested after
36 hours. The experiment for the incorporation of [18O2] follows
the procedure described previously.[25] During the cultivation of the
strain in medium A, 1260 mL of 18O2 and 400 mL of 16O2 were
taken up.[6] Workup as described before yielded labelled 1 in the
following amounts: 23 mg/L ([1-13C]acetate), 10 mg/L ([18O2] ex-
periment).
32.3 (C-3), 33.8 (C-13), 48.4 (C-4), 69.2 (C-5), 71.1 (C-14), 74.1 (C-
8), 127.9, 129.3 (ϫ 2), 132.2 (ϫ 2), 133.1 (phenyl C), 130.2 (C-6),
131.8 (C-7), 132.5 (C-10), 133.0 (C-9), 171.3 (C-2). – EI-MS
(70 eV): m/z (%) ϭ 362.1551 (22) [Mϩ, calcd. for C20H26O4S and
found], 344 (4) [Mϩ – H2O], 252 (7), 182 (100), 180 (58), 163 (33),
135 (21), 109 (33), 91 (19), 84 (25), 55 (23).
(4S,5S,6E,8S,9E,14R)-5,8-Dihydroxy-14-methyl-4-phenylthio-
oxacyclotetradeca-6,9-dien-2-one (4a): M.p. 124 °C. – Rf ϭ 0.86
(CHCl3/MeOH, 9:1). – IR (KBr): ν˜ ϭ 3301 cm–1, 1737, 1672, 1641,
1581. UV (CH3CN): λmax (lg ε) ϭ 206 nm (sh) (4.32), 255 (3.81). –
[α]2D0 ϭ ϩ92 (c ϭ 2.51 in MeOH). – CD (CH3CN): λextr. ([Θ]22) ϭ
Mutolide [(3E,5S,6E,8S,9E,14R)-5,8-Dihydroxy-14-methyloxacyclo-
tetradeca-3,6,9-trien-2-one] (1): Soluble in methanol or acetone; in-
soluble in n-hexane or water. M.p. 168 °C. – Rf value: 0.45 (CHCl3/
MeOH, 9:1). – IR (KBr): ν˜ ϭ 3308 cm–1 (OH), 1708 (CϭO), 1640
(CϭC). – UV (CD3CN): λmax (lg ε) ϭ 192 (4.21), 234 (sh) (3.68). –
[α]2D0 ϭ –61 (c ϭ 1.79 in CD3CN). – CD (CD3CN): λextr. ([Θ]22) ϭ
234 (–39300). – 1H NMR (300 MHz, [D6]acetone): see Table 1.;
(300 MHz, CD3OD): see Table 1. – 13C NMR (75.5 MHz, [D6]ace-
tone): see Table 1. – EI-MS (70 eV): m/z (%) ϭ 252.1361 (3) [Mϩ,
calcd. for C14H20O4 and found], 234 (3) [Mϩ – H2O], 151 (43), 109
(71), 95 (75), 81 (96), 55 (100). – C14H20O4 (252.3): calcd. C 66.65,
H 7.99; found C 66.34, H 8.21.
208 nm (sh) (30900), 228 (–4300), 255 (5600).
–
1H NMR
(300 MHz, CDCl3): δ ϭ 1.15 (d, J15,14 ϭ 7.0 Hz, 15-H3), 1.38–1.53
(m, 12-H2, 13Ha), 1.53–1.68 (m, 13-Hb), 1.86–2.00 (m, 11-Ha),
2.06–2.10 (m, 11-Hb), 2.60 (dd, J3a,3b ϭ 17.0 Hz, J3a,4 ϭ 6.5 Hz, 3-
Ha), 2.77 (dd, J3a,3b ϭ 17.0 Hz, J3b,4 ϭ 3.5 Hz, 3-Hb), 3.10 (br,
OH), 3.24 (ddd, J4,5 ϭ 8.5 Hz, J4,3a ϭ 6.5 Hz, J4,3b ϭ 3.5 Hz, 4-
H), 4.42 (t, J4,5 ϭ J6,5 ϭ 8.0 Hz, 5-H), 4.63 (m, 8-H), 4.83 (m, 14-
H), 5.45 (dd, J9,10 ϭ 15.0 Hz, J9,8 ϭ 6.5 Hz, 9-H), 5.56 (dd, J10,9 ϭ
15.0 Hz, J10,11 ϭ 6.5 Hz, 10-H), 5.71 (ddd, J6,7 ϭ 15.0 Hz, J6,5
ϭ
7.5 Hz, J ϭ 1.0 Hz, 6-H), 5.88 (dd, J7,6 ϭ 15.0 Hz, J ϭ 4.0 Hz, 7-
H), 7.25–7.33 (m, 3 aromatic H), 7.46 (m, 2 aromatic H). – 13C
NMR (75.5 MHz, CDCl3): δ ϭ 18.7 (14-Me), 21.8 (C-12), 30.2 (C-
11), 32.7 (C-13), 37.7 (C-3), 52.6 (C-4), 70.8 (C-14), 71.0 (C-8), 73.8
(C-5), 126.4 (C-6), 127.5, 129.1 (ϫ 2), 132.2 (ϫ 2), 134.1 (phenyl
C), 131.0 (C-10), 132.3 (C-9), 136.9 (C-7), 170.0 (C-2). – EI-MS
(70 eV): m/z (%) ϭ 362.1551 (22) [Mϩ, calcd. for C20H26O4S and
found], 344 (3) [Mϩ – H2O], 252 (5), 182 (100), 180 (64), 163 (32),
135 (23), 109 (25), 91 (14), 84 (24), 55 (16).
X-Ray Crystal-Structure Analysis of 2:[26] Compound 2 (molecular
formula C14H20O4, Mr 252.3) was crystallized by concentrating a
saturated solution of 1 in acetone at 4 °C. Crystal size 0.15 ϫ 0.2
ϫ 0.2 mm, orthorhombic, space group P212121, a ϭ 523.9(1), b ϭ
759.9(1), c ϭ 3430.2(7) pm, α ϭ β ϭ γ ϭ 90°, V ϭ 1.366 nm3, Z ϭ
4, Dcalcd. ϭ 1.227 Mg/m3, µ ϭ 0.089 mm–1, Stoe–Siemens–Huber
diffractometer coupled to a Siemens CCD area detector with
graphite-monochromated Mo-Kα radiation (λ ϭ 0.71073 ), –140
°C, Θ range ϭ 2.37–25.08°, 25168 reflections measured, 2406
unique. Structure solved by direct methods using SHELXS-97[27]
and refined against F2 on all data by full-matrix least squares with
SHELXL-97.[28] A riding model with idealised hydrogen geometry
was employed, the anisotropic refinement converged at R1 ϭ 0.0449
for F Ͼ 2σ(F) and wR2 (F2) ϭ 0.1184 for all reflections.
Preparation of Mosher’s Esters:[11] To 5 mg of 4a in 2 mL of CH2Cl2
were sequentially added 0.2 mL pyridine, 3 mg 4-(dimethylamino)-
pyridine, and 20 mg of (R)-(–)-α-methoxy-α-(trifluoromethyl)phen-
ylacetyl chloride [(R)-MTPA-Cl]. The mixture was stirred for about
12 h at room temperature, checked with TLC to make sure that the
reaction was complete, and passed through a disposable pipette (0.4
ϫ 5 cm) containing silica gel (ICN Silica 32–63), and eluted with
10 mL of CH2Cl2. The oily residue was dried in vacuo and purified
by chromatography on Sephadex LH-20 (acetone) to give the (S)-
MTPA Mosher ester 4b (10 mg). With (S)-(ϩ)-α-methoxy-α-(tri-
fluoromethyl)phenylacetyl chloride the (R)-MTPA Mosher ester 4c
was obtained (11 mg). Both yields were Ͼ95%. For partial 1H-
NMR assignments of 4b and 4c see Table 2.
Preparation of 3 and 4a: 55 mg of 2 in 2 mL of acetone were cooled
to –78 °C, and added to a solution of 24 mg of thiophenol and
22 mg of triethylamine in 1 mL of acetone at –78 °C. The mixture
was stirred for 30 min and allowed to warm up to room temper-
ature. After stirring for additional 2 h the solvent was evaporated
in vacuo. The oily residue was purified by chromatography on silica
gel [column 40 ϫ 1.5 cm, CH2Cl2/acetone (97:3)] to yield 18 mg
(22%) of 3 and 58 mg (73%) of 4a.
Acknowledgments
(4R,5S,6E,8S,9E,14R)-5,8-Dihydroxy-14-methyl-4-phenylthiooxa-
cyclotetradeca-6,9-dien-2-one (3): M.p. 145 °C. – Rf ϭ 0.88 (CHCl3/
MeOH, 9:1). – IR (KBr): ν˜ ϭ 3417 cm–1, 3253, 1722, 1658, 1628,
1582. – UV (CH3CN): λmax (lg ε) ϭ 206 nm (sh) (4.35), 256
(3.79). – [α]2D0 ϭ –50 (c ϭ 1.03 in MeOH). – CD (CH3CN): λextr.
([Θ]22) ϭ 212 nm (–48100), 230 (2400), 254 (-9400). – 1H NMR
(500 MHz, CDCl3): δ ϭ 1.14 (d, J15,14 ϭ 6.0 Hz, 15-H3), 1.48 (m,
12-H2), 1.51 (m, 13-Ha), 1.60 (m, 13-Hb), 1.94 (m, 11-Ha), 2.13 (m,
11-Hb), 2.25 (ddd, J3a,3b ϭ 18.0 Hz, J3,4 ϭ 2.0 Hz, J3,5 ϭ 1.0 Hz,
3-Ha), 2.77 (dd, J3a,3b ϭ 18.0 Hz, J3,4 ϭ 9.5 Hz, 3-Hb), 3.94 (ddd,
J4,3b ϭ 9.5 Hz, J4,3a ϭ 2.0 Hz, J4,5 ϭ 2.0 Hz, 4-H), 4.27 (m, 5-H),
4.49 (t, J8,7 ϭ J8,9 ϭ 7.0 Hz, 8-H), 4.70 (m, 14-H), 5.48 (ddd, J6,7 ϭ
15.5 Hz, J6,5 ϭ 4.0 Hz, J ϭ 1.0 Hz, 6-H), 5.53 (J9,10 ϭ 15.0 Hz,
J9,8 ϭ 7.0 Hz, 9-H), 5.64 (J10,9 ϭ 15.0 Hz, J10,11 ϭ 7.0 Hz, 10-H),
5.85 (ddd, J7,6 ϭ 15.5 Hz, J7,8 ϭ 8.0 Hz, J7,5 ϭ 2.0 Hz, 7-H), 7.24–
7.33 (m, 3 aromatic H), 7.44–7.47 (m, 2 aromatic H). – 13C NMR
We thank J. Gerber-Nolte for technical assistance, Dr. Rheinheimer
(BASF AG, Ludwigshafen) for providing us with tricyclazole and
Novartis Pharma AG (Basel) for providing us with the wild type
strain. Part of this work was granted by the Deutsche Forschungs-
gemeinschaft (Graduiertenkolleg 227).
[1]
C. Puder, A. Zeeck, W. Beil, J. Antibiotics, in press.
[2]
F. Petersen, T. Moerker, F. Vanzanella, H. H. Peter, J. Antibi-
otics 1994, 47, 1098–1103.
[3]
R. Thiergardt, G. Rihs, P. Hug, H. H. Peter, Tetrahedron, 1995,
51, 733–742.
[4]
H. B. Bode, A. Zeeck, in preparation.
H.-J. Schiewe, A. Zeeck, J. Antibiotics 1999, 52, 635–642.
H. B. Bode, B. Wegner, A. Zeeck, J. Antibiotics 2000, 153–157.
S. Grabley, R. Thiericke, A. Zeeck, in: Drug Discovery from
[5]
[6]
[7]
Nature, (Eds.: S. Grabley, R. Thiericke), Springer, Berlin-Heid-
elberg, 1999, 124–148.
Eur. J. Org. Chem. 2000, 1451Ϫ1456
1455